Rights

Search documents
X @Elon Musk
Elon Musk· 2025-06-14 08:30
The same people who blame the West for everything also consider it a human rights violation to stop the rest of Earth from moving here 🤔 ...
FULL CONVO: Ta-Nehisi Coates and Chris Hayes on protests in America and more
MSNBC· 2025-06-14 00:45
Tanahasi Coats is a national book award-winning author and journalist. His acclaimed work, Between the World and Me, is being re-released in paperback on its 10th anniversary next week. And his most recent book, The Message, is out.It's good to have you. Thanks for having me, Chris. We have not gotten a chance to talk on air in a bit.A lot has happened. You think. Well, we got a US military parade on the birthday of the president of the United States, ostensibly for the armed services.Um, we've got deployme ...
Atico Mining Files Amended and Restated Rights Offering Circular and LIFE Offering Document
Globenewswire· 2025-06-13 22:30
Core Viewpoint - Atico Mining Corporation is conducting a Rights Offering and a LIFE Offering to raise a total of approximately $8,536,592 to support its operations and financial commitments [3][4]. Group 1: Offerings Details - The Rights Offering aims to raise gross proceeds of up to approximately $5,336,592, while the LIFE Offering is expected to generate up to approximately $3,200,000 [3]. - The amended Offering Documents include a term sheet with Trafigura PTE. Ltd. regarding an amendment and extension of the existing secured credit agreement [2][3]. - The Offering Documents will be available on SEDAR+ and the company's website for prospective investors [4]. Group 2: Company Overview - Atico Mining Corporation focuses on exploring, developing, and mining copper and gold projects in Latin America, generating significant cash flow from the El Roble mine and developing the La Plata VMS project in Ecuador [6].
'Never seen anything like this': Robinson says Padilla incident is 'not a good look' for admin
MSNBC· 2025-06-13 17:20
Joining me now, MSNBC legal analyst and former US attorney Joyce Vance and MSNBC political analyst and Pulitzer Prizewinning journalist Eugene Robinson. Joyce, I'll start with you. The ruling on Trump's use of the National Guard in California, where do you think it goes from here and what does it tell us about writing precedent in real time? Right. So, it's an amazing opinion written by Justice Brier. I know people were disappointed early on when he took two days to set a hearing rather than immediately iss ...
Empathy as a Lifeline | Anu Suraj | TEDxFISAT
TEDx Talks· 2025-06-13 15:08
Hello everyone. A very good morning to you all. I'm Anu Suraj. I'm a trauma informed therapist and I'm an advocate for child rights and safety and I'm also a child right and safety educator for the past 13 years. Today I would like you all to reflect on something. I would like to put a question forward. What if every child in this world was given a chance to speak their truth? How will the world look like? Imagine yourself as a child trapped in silence, unable to speak out about the abuse that has been sile ...
Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds
Globenewswire· 2025-06-13 11:00
TORONTO, June 13, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce its intention to declare a special dividend consisting of Contingent Value Rights (the “CVRs”) to be issued on a 1:1 basis to holders of the Company’s Class B Subordinate Voting Shares. Each CVR will entitle the holder to receive a pro ra ...
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 2, 2025
Globenewswire· 2025-06-13 05:00
Core Points - The Company is convening an extraordinary shareholders' meeting on July 2, 2025, at 2:00 p.m. CET, with an option for remote participation via video conference [2][3] - The agenda includes a proposal to amend the articles of association to allow shareholders holding at least 5% of outstanding shares for three years to nominate directors [5][6] - Shareholders must register by June 18, 2025, and notify the Company of their intention to participate by June 26, 2025 [13][14] Meeting Details - The meeting will be held at the Company's seat, with video conference facilities for remote attendees [2][3] - Attendance registration will begin at 1:45 p.m. CET on the day of the meeting [4] - Voting can be conducted by mail or by proxy, with specific forms required for these processes [17][18] Voting and Participation - Each share entitles the holder to one vote, and decisions require a 75% majority for certain agenda items [28][29] - Shareholders wishing to ask questions must submit them by June 26, 2025, and answers will be provided during the meeting [24] - Documentation related to the meeting is available on the Company's website and can be requested via email [25]
'Sold their soul for Donald Trump': Rep. LaMonica McIver on Republicans
MSNBC· 2025-06-13 01:45
California Senator Alex Padilla forcibly removed from and handcuffed at a news conference held by Homeland Security Secretary Christy Gnome. The escalation is eerily reminiscent of the scene outside that ICE detention facility in New Jersey just last month. That incident resulted this week in the indictment of Congresswoman Lam Monica Mcver by a federal grand jury.The congresswoman is facing three counts of forcibly impeding and interfering with federal law enforcement officers. She says she plans to plead ...
CIVI Lead Plaintiff Deadline Approaching – CIVI Stockholders Should Contact Robbins LLP for Information About Leading the Civitas Resources, Inc. Class Action Lawsuit
GlobeNewswire News Room· 2025-06-12 22:25
Core Viewpoint - A class action lawsuit has been filed against Civitas Resources, Inc. for allegedly misleading investors about its production capabilities and financial condition during the specified class period [1][2]. Allegations - Civitas is accused of failing to disclose significant reductions in oil production expected in 2025 due to declines after a production peak in Q4 2024 and a low TIL count at the end of 2024 [2]. - The company would need to acquire additional acreage and development locations to increase oil production, which would incur significant debt and potentially require selling corporate assets [2]. - Financial conditions would necessitate disruptive cost-reduction measures, including a significant workforce reduction [2]. - The company's business and financial prospects, as well as operational capabilities, were allegedly overstated [2]. Stock Price Impact - Following the revelation of these issues on February 24, 2025, Civitas's stock price dropped by $8.95 per share, representing a decline of over 18%, closing at $40.35 per share on February 25, 2025 [2]. Class Action Participation - Shareholders may be eligible to participate in the class action, with a deadline to file as lead plaintiff by July 1, 2025 [3]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [3]. Company Background - Civitas Resources, Inc. is an independent exploration and production company focused on crude oil and liquids-rich natural gas in the Denver-Julesburg Basin in Colorado and the Permian Basin in Texas and New Mexico [1].
PEPG Investor Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against PepGen Inc.
Prnewswire· 2025-06-12 22:19
Group 1 - A class action has been filed on behalf of investors who purchased PepGen Inc. (NASDAQ:PEPG) securities between March 7, 2024, and March 3, 2025 [1] - PepGen is a clinical-stage biotechnology company focused on developing oligonucleotide therapeutics for severe neuromuscular and neurologic diseases, with its lead product candidate being PGN-EDO51 for Duchenne muscular dystrophy (DMD) [1] - Allegations against PepGen include misleading investors about the effectiveness and safety of PGN-EDO51, deficiencies in the CONNECT2 study, and overstated clinical and commercial prospects [2] Group 2 - On January 29, 2025, PepGen reported safety concerns in the CONNECT1 study and FDA concerns regarding the CONNECT2 study, leading to a stock price drop of $0.40 per share (21.74%) [3] - Following a press release on March 4, 2025, announcing a voluntary pause of the CONNECT2 study, PepGen's stock price fell by $0.53 per share (18.86%) [4] - Shareholders interested in participating in the class action must file a motion for lead plaintiff by August 8, 2025 [5]